Anti-obesity therapeutics are referred as the treatment that reduces and control the body weight. The obesity is rising due to the lack of physical activities, improper or lack of sleep, high calorie diet, and fast food and heredity history of the person. The ideal anti-obesity therapeutics follows mechanisms that regulate energy balance which have substantial built-in-redundancy and overlap with other physiological functions of the body.
This report elaborates the market size, market characteristics, and market growth of the Anti-Obesity Therapeutics industry, and breaks down according to the type, application, and consumption area of Anti-Obesity Therapeutics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Anti-Obesity Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
ALSO READ : http://www.marketwatch.com/story/anti-obesity-therapeutics-market-r...

Key players in the global Anti-Obesity Therapeutics market covered in Chapter 13:
Alizyme
Eisai Company
Norgine Pharmaceuticals Ltd.
Shionogi USA
Novo Nordisk
BoehringerIngelheim GmbH
Rhythm Pharmaceuticals
Vivus
FlaxoSithKline plc.
Zafgen
Pfizer
Bristol-Myers Squibb
Takeda Pharmaceutical
In Chapter 6, on the basis of types, the Anti-Obesity Therapeutics market from 2015 to 2025 is primarily split into:
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-diffrac...
In Chapter 7, on the basis of applications, the Anti-Obesity Therapeutics market from 2015 to 2025 covers:
Hospital Use
Clinic Use
Household
Other
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-modifie...
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-uniform...
Table of Contents
1 Anti-Obesity Therapeutics Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Anti-Obesity Therapeutics Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Anti-Obesity Therapeutics Market Forces
3.1 Global Anti-Obesity Therapeutics Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Anti-Obesity Therapeutics Market - By Geography
4.1 Global Anti-Obesity Therapeutics Market Value and Market Share by Regions
4.1.1 Global Anti-Obesity Therapeutics Value ($) by Region (2015-2020)
4.1.2 Global Anti-Obesity Therapeutics Value Market Share by Regions (2015-2020)
4.2 Global Anti-Obesity Therapeutics Market Production and Market Share by Major Countries
4.2.1 Global Anti-Obesity Therapeutics Production by Major Countries (2015-2020)
4.2.2 Global Anti-Obesity Therapeutics Production Market Share by Major Countries (2015-2020)
4.3 Global Anti-Obesity Therapeutics Market Consumption and Market Share by Regions
4.3.1 Global Anti-Obesity Therapeutics Consumption by Regions (2015-2020)
4.3.2 Global Anti-Obesity Therapeutics Consumption Market Share by Regions (2015-2020)
5 Anti-Obesity Therapeutics Market - By Trade Statistics
5.1 Global Anti-Obesity Therapeutics Export and Import
5.2 United States Anti-Obesity Therapeutics Export and Import (2015-2020)
5.3 Europe Anti-Obesity Therapeutics Export and Import (2015-2020)
5.4 China Anti-Obesity Therapeutics Export and Import (2015-2020)
5.5 Japan Anti-Obesity Therapeutics Export and Import (2015-2020)
5.6 India Anti-Obesity Therapeutics Export and Import (2015-2020)
5.7 ...
6 Anti-Obesity Therapeutics Market - By Type
6.1 Global Anti-Obesity Therapeutics Production and Market Share by Types (2015-2020)
6.1.1 Global Anti-Obesity Therapeutics Production by Types (2015-2020)
6.1.2 Global Anti-Obesity Therapeutics Production Market Share by Types (2015-2020)
6.2 Global Anti-Obesity Therapeutics Value and Market Share by Types (2015-2020)
6.2.1 Global Anti-Obesity Therapeutics Value by Types (2015-2020)
6.2.2 Global Anti-Obesity Therapeutics Value Market Share by Types (2015-2020)
6.3 Global Anti-Obesity Therapeutics Production, Price and Growth Rate of Centrally Acting Anti-obesity Drugs (2015-2020)
6.4 Global Anti-Obesity Therapeutics Production, Price and Growth Rate of Peripherally Acting Anti-obesity Drugs (2015-2020)
7 Anti-Obesity Therapeutics Market - By Application
7.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Anti-Obesity Therapeutics Consumption by Applications (2015-2020)
7.1.2 Global Anti-Obesity Therapeutics Consumption Market Share by Applications (2015-2020)
7.2 Global Anti-Obesity Therapeutics Consumption and Growth Rate of Hospital Use (2015-2020)
7.3 Global Anti-Obesity Therapeutics Consumption and Growth Rate of Clinic Use (2015-2020)
7.4 Global Anti-Obesity Therapeutics Consumption and Growth Rate of Household (2015-2020)
7.5 Global Anti-Obesity Therapeutics Consumption and Growth Rate of Other (2015-2020)
8 North America Anti-Obesity Therapeutics Market
8.1 North America Anti-Obesity Therapeutics Market Size
8.2 United States Anti-Obesity Therapeutics Market Size
8.3 Canada Anti-Obesity Therapeutics Market Size
8.4 Mexico Anti-Obesity Therapeutics Market Size
8.5 The Influence of COVID-19 on North America Market
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-printin...

9 Europe Anti-Obesity Therapeutics Market Analysis
9.1 Europe Anti-Obesity Therapeutics Market Size
9.2 Germany Anti-Obesity Therapeutics Market Size
9.3 United Kingdom Anti-Obesity Therapeutics Market Size
9.4 France Anti-Obesity Therapeutics Market Size
9.5 Italy Anti-Obesity Therapeutics Market Size
9.6 Spain Anti-Obesity Therapeutics Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Anti-Obesity Therapeutics Market Analysis
10.1 Asia-Pacific Anti-Obesity Therapeutics Market Size
10.2 China Anti-Obesity Therapeutics Market Size
10.3 Japan Anti-Obesity Therapeutics Market Size
10.4 South Korea Anti-Obesity Therapeutics Market Size
10.5 Southeast Asia Anti-Obesity Therapeutics Market Size
10.6 India Anti-Obesity Therapeutics Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Anti-Obesity Therapeutics Market Analysis
11.1 Middle East and Africa Anti-Obesity Therapeutics Market Size
11.2 Saudi Arabia Anti-Obesity Therapeutics Market Size
11.3 UAE Anti-Obesity Therapeutics Market Size
11.4 South Africa Anti-Obesity Therapeutics Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Anti-Obesity Therapeutics Market Analysis
12.1 South America Anti-Obesity Therapeutics Market Size
12.2 Brazil Anti-Obesity Therapeutics Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Alizyme
13.1.1 Alizyme Basic Information
13.1.2 Alizyme Product Profiles, Application and Specification
13.1.3 Alizyme Anti-Obesity Therapeutics Market Performance (2015-2020)
13.2 Eisai Company
13.2.1 Eisai Company Basic Information
13.2.2 Eisai Company Product Profiles, Application and Specification
13.2.3 Eisai Company Anti-Obesity Therapeutics Market Performance (2015-2020)
13.3 Norgine Pharmaceuticals Ltd.
13.3.1 Norgine Pharmaceuticals Ltd. Basic Information
13.3.2 Norgine Pharmaceuticals Ltd. Product Profiles, Application and Specification
13.3.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Market Performance (2015-2020)
13.4 Shionogi USA
13.4.1 Shionogi USA Basic Information
13.4.2 Shionogi USA Product Profiles, Application and Specification
13.4.3 Shionogi USA Anti-Obesity Therapeutics Market Performance (2015-2020)
13.5 Novo Nordisk
13.5.1 Novo Nordisk Basic Information
13.5.2 Novo Nordisk Product Profiles, Application and Specification
13.5.3 Novo Nordisk Anti-Obesity Therapeutics Market Performance (2015-2020)
13.6 BoehringerIngelheim GmbH
13.6.1 BoehringerIngelheim GmbH Basic Information
13.6.2 BoehringerIngelheim GmbH Product Profiles, Application and Specification
13.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Market Performance (2015-2020)
13.7 Rhythm Pharmaceuticals
13.7.1 Rhythm Pharmaceuticals Basic Information
13.7.2 Rhythm Pharmaceuticals Product Profiles, Application and Specification
13.7.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Market Performance (2015-2020)
13.8 Vivus
13.8.1 Vivus Basic Information
13.8.2 Vivus Product Profiles, Application and Specification
13.8.3 Vivus Anti-Obesity Therapeutics Market Performance (2015-2020)
13.9 FlaxoSithKline plc.
13.9.1 FlaxoSithKline plc. Basic Information
13.9.2 FlaxoSithKline plc. Product Profiles, Application and Specification
13.9.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Market Performance (2015-2020)
13.10 Zafgen
13.10.1 Zafgen Basic Information

....contiued

CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105